Bank of New York Mellon’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $773K | Buy |
77,547
+12,741
| +20% | +$127K | ﹤0.01% | 3246 |
|
|
2025
Q1 | $387K | Sell |
64,806
-2,441
| -4% | -$14.6K | ﹤0.01% | 3559 |
|
|
2024
Q4 | $516K | Sell |
67,247
-35,918
| -35% | -$276K | ﹤0.01% | 3485 |
|
|
2024
Q3 | $1.05M | Sell |
103,165
-18,085
| -15% | -$185K | ﹤0.01% | 3107 |
|
|
2024
Q2 | $1.8M | Buy |
121,250
+5,409
| +5% | +$80.3K | ﹤0.01% | 2851 |
|
|
2024
Q1 | $1.58M | Sell |
115,841
-8,310
| -7% | -$113K | ﹤0.01% | 2896 |
|
|
2023
Q4 | $1.36M | Sell |
124,151
-154,808
| -55% | -$1.7M | ﹤0.01% | 3023 |
|
|
2023
Q3 | $3.05M | Buy |
278,959
+17,090
| +7% | +$187K | ﹤0.01% | 2567 |
|
|
2023
Q2 | $3.47M | Sell |
261,869
-86
| -0% | -$1.14K | ﹤0.01% | 2525 |
|
|
2023
Q1 | $3.57M | Sell |
261,955
-12,418
| -5% | -$169K | ﹤0.01% | 2484 |
|
|
2022
Q4 | $5.36M | Buy |
274,373
+60,082
| +28% | +$1.17M | ﹤0.01% | 2307 |
|
|
2022
Q3 | $4.08M | Buy |
214,291
+33,780
| +19% | +$644K | ﹤0.01% | 2401 |
|
|
2022
Q2 | $3.72M | Sell |
180,511
-6,289
| -3% | -$130K | ﹤0.01% | 2480 |
|
|
2022
Q1 | $6.01M | Buy |
186,800
+84,186
| +82% | +$2.71M | ﹤0.01% | 2321 |
|
|
2021
Q4 | $4.78M | Buy |
102,614
+31,154
| +44% | +$1.45M | ﹤0.01% | 2485 |
|
|
2021
Q3 | $1.93M | Buy |
71,460
+13,330
| +23% | +$360K | ﹤0.01% | 2992 |
|
|
2021
Q2 | $1.49M | Buy |
58,130
+3,019
| +5% | +$77.4K | ﹤0.01% | 3179 |
|
|
2021
Q1 | $1.88M | Buy |
55,111
+13,851
| +34% | +$474K | ﹤0.01% | 2954 |
|
|
2020
Q4 | $1.4M | Buy |
41,260
+12,191
| +42% | +$412K | ﹤0.01% | 3049 |
|
|
2020
Q3 | $718K | Buy |
+29,069
| New | +$718K | ﹤0.01% | 3308 |
|